Patient/advocate Diane Redington and Dr. Marcela del Carmen discuss the importance of clinical trials and the extreme lack of funding for gynecological cancer research. This is part eight of a nine part series. Dr. Marcela del Carmen explains that they are on the forefront of major discoveries in understanding the biology of this cancer, and […]
Patient/Advocate Diane Redington and Dr. Whitfield Growden discuss availability, eligibility and decisions regarding clinical trials and the differences in treatment options. This is part six of a nine part series. Dr. Growden explains that carcinosarcomas are generally excluded from clinical trials, although uterine carcinosarcoma has been allowed in some trials. Soon, they are going to […]
Patient/advocate Diane Redington and Dr. Whitfield Growden discuss current scientific findings and clinical trials in ovarian and uterine carcinosarcoma. This is part three of a nine part series. Dr. Growden discusses how they have examined tumors (from Mass General’s tumor bank) of the fallopian tubes, ovary, uterus, and vagina. They found approximately 150 different mutations […]
The second of two interviews conducted on January 5, 2017, with Diane Redington and Dr. Growdon on the topic of carcinosarcoma. This interview discusses: genomic analysis of carcinosarcoma, patterns of resistance, immunotherapy and clinical trials.
The following transcript is from an interview between Dr. Whitfield Growdon (MDC), a leading GYN Oncological Surgeon from Mass General Cancer Center in Boston and Diane Redington (DR), a woman with a Gynecological Carcinosarcoma (GCS) who is seeking to motivate researchers to advance the science and uncover knowledge about carcinosarcoma and find a cure for this cancer. This interview discusses diagnosis and treatment of MMMT.
An interview with Dr. Birrer, leading researcher, on emerging immunotherapies with Gynecologic Carcinosarcoma cancer (MMMT).
An interview with Dr. Birrer and Diane Redington about the initial results of research being done on Gynecologic Carcinosarcoma at Mass General Hospital.